Danmei Zhang

Munich, BY 81737, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Distinct Mutation Signatures in Peripheral Blood Mitochondrial DNA from Liquid Biopsy Reveal Insights into Pancreatic Cancer.

Distinct Mutation Signatures in Peripheral Blood Mitochondrial DNA from Liquid Biopsy Reveal Insights into Pancreatic Cancer.

Journal: Cells

Published: January 19, 2026

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Journal: Gut

Published: October 23, 2025

The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in Germany.

The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in Germany.

Journal: International journal of cancer

Published: September 23, 2025

Correction: Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.

Correction: Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.

Journal: Targeted oncology

Published: August 27, 2025

Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic.

Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic.

Journal: Scientific reports

Published: July 01, 2025

Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study.

Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study.

Journal: JHEP reports : innovation in hepatology

Published: May 29, 2025

Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.

Author Correction: Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer.

Journal: Nature

Published: May 13, 2025

Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.

Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board.

Journal: Targeted oncology

Published: May 04, 2025

Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in Germany.

Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in Germany.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 30, 2025

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

Clinical-scale, modular manufacturing of tumor-reactive TILs using a closed and automated culture system.

Journal: Frontiers in immunology

Published: August 19, 2024

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: July 02, 2024

Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.

Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial.

Journal: The lancet. Gastroenterology & hepatology

Published: February 16, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026